1. Ndowa, FJ, Francis, JM, Machiha, A, et al. Gonococcal antimicrobial resistance: perspectives from the African region. Sex Transm Infect 2013; 89(Suppl 4): iv11–iv15.
Google Scholar | Crossref | Medline2. Van Dyck, E, Karita, E, Abdellati, S, et al. Antimicrobial susceptibilities of Neisseria gonorrhoeae in Kigali, Rwanda, and trends of resistance between 1986 and 2000. Sex Transm Dis 2001; 28(9): 539–545.
Google Scholar | Crossref | Medline3. Moodley, P, Sturm, AW. Ciprofloxacin-resistant gonorrhoea in South Africa. Lancet 2005; 366(9492): 1159.
Google Scholar | Crossref | Medline4. Maduna, LD, Kock, MM, van der Veer, B, et al. Antimicrobial resistance of Neisseria gonorrhoeae isolates from high-risk Men in Johannesburg, South Africa. Antimicrob Agents Chemother 2020; 64(11); e00906-20.
Google Scholar | Crossref | Medline5. Juma, M, Sankaradoss, A, Ndombi, R, et al. Antimicrobial resistance profiling and phylogenetic analysis of Neisseria gonorrhoeae clinical isolates from Kenya in a resource-limited setting. Front Microbiol 2021; 12: 647565.
Google Scholar | Crossref | Medline6. Mabonga, E, Parkes-Ratanshi, R, Riedel, S, et al. Complete ciprofloxacin resistance in gonococcal isolates in an urban Ugandan clinic: findings from a cross-sectional study. Int J STD AIDS 2019; 30(3): 256–263.
Google Scholar | SAGE Journals | ISI7. Van Dyck, E, Crabbé, F, Nzila, N, et al. Increasing resistance of Neisseria gonorrhoeae in west and central Africa. Consequence on therapy of gonococcal infection. Sex Transm Dis 1997; 24(1): 32–37.
Google Scholar | Crossref | Medline8. Bogaerts, J, Tello, WM, Akingeneye, J, et al. Effectiveness of norfloxacin and ofloxacin for treatment of gonorrhoea and decrease of in vitro susceptibility to quinolones over time in Rwanda. Genitourin Med 1993; 69(3): 196–200.
Google Scholar | Medline9. Ministry of Health and Rwanda. Ro . National Guidelines for Prevention and Management of HIV and STIs 2016.
Google Scholar10. Ministry of Health and Rwanda. Ro . National guidelines for and management of viral hepatitis b, c and sexually transmitted infections 2019.
Google Scholar11. CDC . Recommendations for the laboratory-based detection of Chlamydia trachomatis and Neisseria gonorrhoeae--2014. MMWR Recomm Rep 2014; 63(RR-02): 1–19.
Google Scholar12. Karita, E, Nsanzimana, S, Ndagije, F, et al. Implementation and operational research: evolution of couples’ voluntary counseling and testing for HIV in Rwanda: from research to public health practice. J Acquired Immune Defic Syndr 2016; 73(3): e51–e58.
Google Scholar | Crossref | Medline13. Mazzei, A, Ingabire, R, Mukamuyango, J, et al. Community health worker promotions increase uptake of long-acting reversible contraception in Rwanda. Reprod Health 2019; 16(1): 75.
Google Scholar | Crossref | Medline14. Ingabire, R, Nyombayire, J, Hoagland, A, et al. Evaluation of a multi-level intervention to improve postpartum intrauterine device services in Rwanda. Gates Open Res 2018; 2(38): 38.
Google Scholar | Medline15. WHO . WHO Guidelines for the Treatment of Neisseria Gonorrhoeae. http://apps.who.int/iris/bitstream/handle/10665/246114/9789241549691-eng.pdf?sequence=1 (2016, accessed 13 September 2021).
Google Scholar16. CDC . Sexually Transmitted Infections Treatment Guidelines. https://www.cdc.gov/std/treatment-guidelines/STI-Guidelines-2021.pdf (2021, Accessed 13 September 2021).
Google Scholar17. WHO . Multi-drug resistant gonorrhoea. https://www.who.int/news-room/fact-sheets/detail/multi-drug-resistant-gonorrhoea (2021, Accessed 15 December 2020).
Google Scholar